Pharmascience Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Canada
- Registered address
- 100 Boulevard de L'industrie, Candiac, QC J5R 1J1, Canada (CAN)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3002806578 · DUNS 202657094
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-02-13
- VAIDrug Quality Assurance2019-06-18
- NAIDrug Quality Assurance2018-02-05
- NAIDrug Quality Assurance2014-11-17
- NAIDrug Quality Assurance2010-07-13
Drugs this plant is listed as making
4 distinct drugs across 10 products name this site in their FDA label.
- bortezomibPharmascience Inc.
- busulfanPharmascience Inc.
- ganciclovir sodiumPharmascience Inc.
- methotrexatein shortageAntares Pharma, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.